Community-acquired methicillin-resistant Staphylococcus aureus infections

Clinics in Laboratory Medicine

Volumn 24, Issue 2, 2004, Pages 403-418

  Palavecino, Elizabeth ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFAZOLIN; CEFOTAXIME; NAFCILLIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; AUSTRALIA; AUTOPSY; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; CHILD HOSPITALIZATION; CLINICAL PRACTICE; DRUG HYDROLYSIS; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; EPIDEMIC; EUROPE; HOSPITAL INFECTION; HUMAN; IMPETIGO; INTENSIVE CARE; JAPAN; LABORATORY TEST; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NONHUMAN; NURSING HOME; OTITIS MEDIA; PLEURA EFFUSION; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SEPSIS; SKIN ABSCESS; SKIN DEFECT; SKIN INFECTION; STAPHYLOCOCCUS INFECTION; THORAX RADIOGRAPHY; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 2942627689     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2004.03.007     Document Type: Review

References (52)

1. Robertson L., Caley J.P., Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet. 2:1958;233-236
2. Schwarzmann S.W., Adler J.L., Sullivan R.J. Jr., Marine W.M. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med. 127:1971;1037-1041
3. Ruben F.L., Cate T.R. Influenza pneumonia. Semin Respir Infect. 2:1987;122-129
4. Enright M.C., Robinson D.A., Randle G., Feil E.J., Grundmann H., Spratt B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA. 99:2002;7687-7692
5. Barrett F.F., McGehee R.F. Jr., Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med. 279:1968;441-448
6. Everett E.D., McNitt T.R., Rahm A.E. Jr., Stevens D.L., Peterson H.E. Epidemiologic investigation of methicillin resistant Staphylococcus aureus in a burn unit. Mil Med. 143:1978;165-167
7. Herold B.C., Immergluck L.C., Maranan M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 279:1998;593-598
8. Suntharam N., Hacek D., Peterson L.R. Low prevalence of community-acquired methicillin-resistant Staphylococcus aureus in adults at a university hospital in the central United States. J Clin Microbiol. 39:2001;1669-1671
9. Suggs A.H., Maranan M.C., Boyle-Vavra S., Daum R.S. Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. Pediatr Infect Dis J. 18:1999;410-414
10. Shopsin B., Mathema B., Martinez J., et al. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis. 182:2000;359-362
11. Charlebois E.D., Bangsberg D.R., Moss N.J., et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis. 34:2002;425-433
12. Georgopapadakou N.H., Smith S.A., Bonner D.P. Penicillin-binding proteins in a Staphylococcus aureus strain resistant to specific beta-lactam antibiotics. Antimicrob Agents Chemother. 22:1982;172-175
13. Ubukata K., Nonoguchi R., Matsuhashi M., Song M.D., Konno M. Restriction maps of the regions coding for methicillin and tobramycin resistances on chromosomal DNA in methicillin-resistant staphylococci. Antimicrob Agents Chemother. 33:1989;1624-1626
14. Fey P.D., Said-Salim B., Rupp M.E., et al. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 47:2003;196-203
15. Daum R.S., Ito T., Hiramatsu K., et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis. 186:2002;1344-1347
16. Ma X.X., Ito T., Tiensasitorn C., et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 46:2002;1147-1152
17. Aires de Sousa M., de Lencastre H. Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J Clin Microbiol. 41:2003;3806-3815
18. Pan E.S., Diep B.A., Carleton H.A., et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis. 37:2003;1384-1388
19. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 52:2003;88
20. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep. 48:1999;707-710
21. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison-Mississippi, 2000. MMWR Morb Mortal Wkly Rep. 50:2001;919-922
22. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep. 52:2003;793-795
23. Lindenmayer J.M., Schoenfeld S., O'Grady R., Carney J.K. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med. 158:1998;895-899
24. Stacey A.R., Endersby K.E., Chan P.C., Marples R.R. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med. 32:1998;153-154
25. Bartlett P.C., Martin R.J., Cahill B.R. Furunculosis in a high school football team. Am J Sports Med. 10:1982;371-374
26. Sosin D.M., Gunn R.A., Ford W.L., Skaggs J.W. An outbreak of furunculosis among high school athletes. Am J Sports Med. 17:1989;828-832
27. McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 55:2001;77-104
28. Prevost G., Cribier B., Couppie P., et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun. 63:1995;4121-4129
29. Baggett H.C., Hennessy T.W., Leman R., et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol. 24:2003;397-402
30. Baggett HC, Rudolph K, Hennessy TW, et al. Panton-Valentine leukocidin (PVL) is associated with methicillin resistance in an outbreak of community-onset Staphylococcus aureus skin infections-Alaska [abstract 126]. 40th Annual Infectious Disease Society of America Meeting. Chicago, IL, October 24-27, 2002.
31. Lina G., Piemont Y., Godail-Gamot F., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 29:1999;1128-1132
32. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 290:2003;2976-2984
33. Dufour P., Gillet Y., Bes M., et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 35:2002;819-824
34. Gillet Y., Issartel B., Vanhems P., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 359:2002;753-759
35. Vandenesch F., Naimi T., Enright M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 9:2003;978-984
36. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 6th edition M7-A6:2003;National Committee for Clinical Laboratory Standards, Wayne (PA)
37. NCCLS. Performance standards for antimicrobial disk susceptibility tests; approved standard. 8th edition M2-A8:2003;National Committee for Clinical Laboratory Standards, Wayne, PA
38. Resende C.A., Figueiredo A.M. Discrimination of methicillin-resistant Staphylococcus aureus from borderline-resistant and susceptible isolates by different methods. J Med Microbiol. 46:1997;145-149
39. Cavassini M., Wenger A., Jaton K., Blanc D.S., Bille J. Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol. 37:1999;1591-1594
40. Felten A., Grandry B., Lagrange P.H., Casin I. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol. 40:2002;2766-2771
41. NCCLS. Performance standards for antimicrobial susceptibility testing. 14th informational supplement M100-S14. 2004;National Committee for Clinical Laboratory Standards, Wayne (PA)
42. Yamazumi T., Marshall S.A., Wilke W.W., Diekema D.J., Pfaller M.A., Jones R.N. Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus. J Clin Microbiol. 39:2001;53-56
43. Swenson J.M., Williams P.P., Killgore G., O'Hara C.M., Tenover F.C. Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms. J Clin Microbiol. 39:2001;3785-3788
44. Sakoulas G., Gold H.S., Venkataraman L., DeGirolami P.C., Eliopoulos G.M., Qian Q. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol. 39:2001;3946-3951
45. Gorak E.J., Yamada S.M., Brown J.D. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis. 29:1999;797-800
46. Martinez-Aguilar G., Hammerman W.A., Mason E.O. Jr., Kaplan S.L. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 22:2003;593-598
47. Frank A.L., Marcinak J.F., Mangat P.D., et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 21:2002;530-534
48. Johnigan R.H., Pereira K.D., Poole M.D. Community-acquired methicillin-resistant Staphylococcus aureus in children and adolescents: changing trends. Arch Otolaryngol Head Neck Surg. 129:2003;1049-1052
49. Weisblum B. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob Agents Chemother. 39:1995;797-805
50. Chambers H.F. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 10:1997;781-791
51. Louie L., Matsumura S.O., Choi E., Louie M., Simor A.E. Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol. 38:2000;2170-2173
52. Arbique J., Forward K., Haldane D., Davidson R. Comparison of the Velogene Rapid MRSA Identification Assay, Denka MRSA-Screen Assay, and BBL Crystal MRSA ID System for rapid identification of methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis. 40:2001;5-10